The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world
Open accessAbstract
Hepatocellular carcinoma (HCC) is the most frequent primary liver malignancy and the third cause of cancer-related death in the Western Countries. The well-established causes of HCC are chronic liver infections such as hepatitis B virus or chronic hepatitis C virus, nonalcoholic fatty liver disease, consumption of aflatoxins and tobacco smocking. Clinical presentation varies widely; patients can be asymptomatic while symptomatology extends from right upper abdominal quadrant paint and weight loss to obstructive jaundice and lethargy. Imaging is the first key and one of the most important aspects at all stages of diagnosis, therapy and follow-up of patients with HCC. The Barcelona Clinic Liver Cancer Staging System remains the most widely classification system used for HCC management guidelines. Up until now, HCC remains a challenge to early diagnose, and treat effectively; treating management is focused on hepatic resection, orthotopic liver transplantation, ablative therapies, chemoembolization and systemic therapies with cytotocix drugs, and targeted agents. This review article describes the current evidence on epidemiology, symptomatology, diagnosis and treatment of hepatocellular carcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.205 · Cited by 15,660
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Edge, S. B., & Compton, C. C. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0985-4 · Cited by 9,029
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,103
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
Acute Abdomen: A Rare Case of Ruptured Hepatocellular Carcinoma
Gloor, S., Jensen, K. O., Breitenstein, S., Binkert, C. A., Angst, E., & Hetzer, F. H. (2017) · Case Reports in Gastroenterology · doi:10.1159/000463378 · Cited by 5,370
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
WHO Classification of Tumours of the Digestive System
Bosman, F. T. (2010) · Medical Entomology and Zoology · Cited by 5,041
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
Lencioni, R., & Llovet, J. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1247132 · Cited by 4,329
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Bruix, J., Sherman, M., Llovet, J. M., Beaugrand, M., Lencioni, R., Burroughs, A. K., Christensen, E., Pagliaro, L., Colombo, M., & Rodés, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00130-1 · Cited by 4,089
Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
Llovet, J., Brú, C., & Bruix, J. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007122 · Cited by 3,805
Llovet, J. M., Burroughs, A., & Bruix, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14964-1 · Cited by 3,608
Malinchoc, M., Kamath, P. S., Gordon, F. D., Peine, C. J., Rank, J., & ter Borg, P. C. J. (2000) · Hepatology · doi:10.1053/he.2000.5852 · Cited by 2,893
Okuda, K., Ohtsuki, T., Obata, H., Tomimatsu, M., Okazaki, N., Hasegawa, H., Nakajima, Y., & Ohnishi, K. (1985) · Cancer · doi:10.1002/1097-0142(19850815)56:4<918::aid-cncr2820560437>3.0.co;2-e · Cited by 1,931
The model for end-stage liver disease (MELD)
Kamath, P. S., & Kim, R. W. (2007) · Hepatology · doi:10.1002/hep.21563 · Cited by 1,674
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
Llovet, J. M., Di Bisceglie, A. M., Bruix, J., Kramer, B. S., Lencioni, R., Zhu, A. X., Sherman, M., Schwartz, M., Lotze, M., Talwalkar, J., et al. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn134 · Cited by 1,653
Globocan 2000 : cancer incidence, mortality and prevalence worldwide
Ferlay, J., Pisani, P., & Parkin, D. M. (2001) · Medical Entomology and Zoology · Cited by 1,579
Phase II Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma
Abou-Alfa, G. K., Schwartz, L., Ricci, S., Amadori, D., Santoro, A., Figer, A., De Greve, J., Douillard, J.-Y., Lathia, C., Schwartz, B., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.3441 · Cited by 1,195
Diagnosis and Treatment of Hepatocellular Carcinoma
El-Serag, H. B., Marrero, J. A., Rudolph, L., & Reddy, K. R. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.090 · Cited by 1,137
Livraghi, T., Meloni, F., Di Stasi, M., Rolle, E., Solbiati, L., Tinelli, C., & Rossi, S. (2008) · Hepatology · doi:10.1002/hep.21933 · Cited by 1,103
Omata, M., Lesmana, L. A., Tateishi, R., Chen, P.-J., Lin, S.-M., Yoshida, H., Kudo, M., Lee, J. M., Choi, B. I., Poon, R. T. P., et al. (2010) · Hepatology International · doi:10.1007/s12072-010-9165-7 · Cited by 1,026
Evidence-Based Incorporation of Serum Sodium Concentration Into MELD
Biggins, S. W., Kim, W. R., Terrault, N. A., Saab, S., Balan, V., Schiano, T., Benson, J., Therneau, T., Kremers, W., Wiesner, R., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.010 · Cited by 790
Kubota, K., Makuuchi, M., Kusaka, K., Kobayashi, T., Miki, K., Hasegawa, K., Harihara, Y., & Takayama, T. (1997) · Hepatology · doi:10.1002/hep.510260514 · Cited by 730
Preoperative Portal Vein Embolization for Major Liver Resection: A Meta-Analysis
Abulkhir, A., Limongelli, P., Healey, A. J., Damrah, O., Tait, P., Jackson, J., Habib, N., & Jiao, L. R. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e31815f6e5b · Cited by 673
Mazzaferro, V., Bhoori, S., Sposito, C., Bongini, M., Langer, M., Miceli, R., & Mariani, L. (2011) · Liver Transplantation · doi:10.1002/lt.22365 · Cited by 593
Melendez, J. A., Arslan, V., Fischer, M. E., Wuest, D., Jarnagin, W. R., Fong, Y., & Blumgart, L. H. (1998) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(98)00240-3 · Cited by 576
Prospective Evaluation of Pringle Maneuver in Hepatectomy for Liver Tumors by a Randomized Study
Man, K., Fan, S.-T., Ng, I. O. L., Lo, C.-M., Liu, C.-L., & Wong, J. (1997) · Annals of Surgery · doi:10.1097/00000658-199712000-00007 · Cited by 444
Livraghi, T., Bolondi, L., Lazzaroni, S., Marin, G., Morabito, A., Rapaccini, G. L., Salmi, A., & Torzilli, G. (1992) · Cancer · doi:10.1002/1097-0142(19920215)69:4<925::aid-cncr2820690415>3.0.co;2-g · Cited by 406
Liver Anatomy: Portal (and Suprahepatic) or Biliary Segmentation
Couinaud, C. (1999) · Digestive Surgery · doi:10.1159/000018770 · Cited by 400
Yao, F. Y., Bass, N. M., Nikolai, B., Davern, T. J., Kerlan, R., Wu, V., Ascher, N. L., & Roberts, J. P. (2002) · Liver Transplantation · doi:10.1053/jlts.2002.34923 · Cited by 389
Playing Play-Doh to Prevent Postoperative Liver Failure: The “ALPPS” approach
de Santibañes, E., & Clavien, P.-A. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e318248577d · Cited by 381
Botta, F., Giannini, E., Romagnoli, P., Fasoli, A., Malfatti, F., Chiarbonello, B., Testa, E., Risso, D., Colla, G., & Testa, R. (2003) · Gut · doi:10.1136/gut.52.1.134 · Cited by 358
Selection of Patients for Resection of Hepatic Colorectal Metastases: Expert Consensus Statement
Charnsangavej, C., Clary, B., Fong, Y., Grothey, A., Pawlik, T. M., & Choti, M. A. (2006) · Annals of Surgical Oncology · doi:10.1245/s10434-006-9023-y · Cited by 354
Poulou, L. S. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i8.1054 · Cited by 340
Hepatocellular carcinoma (HCC): beyond sorafenib—chemotherapy
Kim, D. W., Talati, C., & Kim, R. (2017) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2016.09.07 · Cited by 333
Growth and spread of hepatocellular carcinoma: A review of 240 consecutive autopsy cases
Yuki, K., Hirohashi, S., Sakamoto, M., Kanai, T., & Shimosato, Y. (1990) · Cancer · doi:10.1002/1097-0142(19901115)66:10<2174::aid-cncr2820661022>3.0.co;2-a · Cited by 327
Epidemiology of hepatocellular carcinoma in USA
El‐Serag, H. B. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00168.x · Cited by 320
Histopathology of hepatocellular carcinoma
Schlageter, M., Terracciano, L. M., D’Angelo, S., & Sorrentino, P. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i43.15955 · Cited by 294
Lencioni, R., de Baere, T., Burrel, M., Caridi, J. G., Lammer, J., Malagari, K., Martin, R. C. G., O’Grady, E., Real, M. I., Vogl, T. J., et al. (2012) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-011-0287-7 · Cited by 287
Facciorusso, A., Di Maso, M., & Muscatiello, N. (2016) · International Journal of Hyperthermia · doi:10.3109/02656736.2015.1127434 · Cited by 267
Aflatoxins as a cause of hepatocellular carcinoma.
Kew, M. C. (2013) · PubMed · Cited by 263
Kubota, K. (1997) · Hepatology · doi:10.1053/jhep.1997.v26.pm0009362359 · Cited by 253
Ogata, S., Belghiti, J., Farges, O., Varma, D., Sibert, A., & Vilgrain, V (2006) · British Journal of Surgery · doi:10.1002/bjs.5341 · Cited by 251
WANG, X., DEGOS, F., DUBOIS, S., TESSIORE, S., ALLEGRETTA, M., GUTTMANN, R., JOTHY, S., BELGHITI, J., BEDOSSA, P., & PARADIS, V (2006) · Human Pathology · doi:10.1016/j.humpath.2006.05.016 · Cited by 228
Dual-Tracer PET/CT Imaging in Evaluation of Metastatic Hepatocellular Carcinoma
Ho, C.-L., Chen, S., Yeung, D. W. C., & Cheng, T. K. C. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.036673 · Cited by 210
Nishino, M., Jackman, D. M., Hatabu, H., Yeap, B. Y., Cioffredi, L.-A., Yap, J. T., Jänne, P. A., Johnson, B. E., & Van den Abbeele, A. D. (2010) · American Journal of Roentgenology · doi:10.2214/ajr.09.3928 · Cited by 201
Present and future possibilities for early diagnosis of hepatocellular carcinoma
Stefaniuk, P. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i4.418 · Cited by 184
Piana, G., Trinquart, L., Meskine, N., Barrau, V., Beers, B. V., & Vilgrain, V. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.023 · Cited by 182
Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma
Lencioni, R. A., Piscaglia, F., & Bolondi, L. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.02.005 · Cited by 140
Park, M., Kim, S., Patel, J., Hajdu, C. H., Gian, R. K., Mannelli, L., Babb, J. S., & Taouli, B. A. (2012) · Hepatology · doi:10.1002/hep.25681 · Cited by 122
A review of hepatocellular carcinoma (HCC) staging systems.
Subramaniam, S., Kelley, R. K., & Venook, A. P. (2013) · PubMed · doi:10.3978/j.issn.2304-3865.2013.07.05 · Cited by 111
Seydel, G. Ş., Kücükoglu, Ö., Altinbasv, A., Demir, O. O., Yılmaz, S., Akkız, H., Otan, E., Sowa, J., & Canbay, A. E. (2016) · PubMed · doi:10.5604/16652681.1212316 · Cited by 98
Histopathology of Hepatocellular Carcinoma
Paradis, V. (2012) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-16037-0_2 · Cited by 96
Al-Sibae, M. R., & Cappell, M. S. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1390-3 · Cited by 88
Advances in management of hepatocellular carcinoma
Allaire, M., & Nault, J. (2017) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000378 · Cited by 78
Bédossa, P., Burt, A. D., Brunt, E. M., Callea, F., Clouston, A. D., Dienes, H., Goodman, Z. D., Gouw, A. S. H., Hübscher, S. G., Roberts, E. A., et al. (2013) · Human Pathology · doi:10.1016/j.humpath.2013.09.020 · Cited by 72
Alfa, G. K. A., Johnson, P., Knox, J. J., Lacava, J. A., Leung, T., Mori, A., Leberre, M., Voliotis, D., & Saltz, L. B. (2007) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(07)71003-0 · Cited by 56
Abou-Alfa, G. K., Amadori, D., Santoro, A., Figer, A., Grève, J. D., Lathia, C. D., Voliotis, D., Anderson, S., Moscovici, M., & Ricci, S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.4518 · Cited by 56
Paraneoplastic syndromes in patients with hepatocellular carcinoma in Taiwan
Luo, J., Hwang, S., Wu, J., Li, C., Hsiao, L., Lai, C., Chiang, J., Lui, W., Chang, F., & Lee, S. (1999) · Cancer · Cited by 54
Biphenotypic (Hepatobiliary) Primary Liver Carcinomas: The Work in Progress
Brunt, E. M., Paradis, V., Sempoux, C. L., & Theise, N. D. (2015) · Hepatic Oncology · doi:10.2217/hep.15.8 · Cited by 52
Hepatitis B and Hepatocellular Carcinoma
Hemming, A. W., Berumen, J. A., & Mekeel, K. L. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2016.06.007 · Cited by 40
Okano (1994) · Oncology Reports · doi:10.3892/or_00000084 · Cited by 38
Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors
Kuei, A. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i27.8271 · Cited by 38
Tumours and tumour-like lesions of the liver
Goodman, Z. D., Terracciano, L., & Wee, A. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3398-8.00014-3 · Cited by 34
Hepatocellular carcinoma (HCC)
Mokbel, K. (2018) · CRC Press eBooks · doi:10.1201/9781315378381-29 · Cited by 25
Outcomes of liver resection for hepatocellular carcinoma in liver transplantation era
Lee, W.-C., Lee, C.-F., Cheng, C.-H., Wu, T.-J., Chou, H.-S., Wu, T.-C., Soong, R.-S., Chan, K., Yu, M.-C., & Chen, M.-F. (2015) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2015.05.024 · Cited by 20
Smoking and hepatocellular carcinoma mortality
Siegel, A. B., Conner, K. M., Wang, S., Jacobson, J. S., Hershman, D. L., Hidalgo, R., Verna, E. C., Halazun, K. J., Brubaker, W. D., Zaretsky, J., et al. (2011) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2011.351 · Cited by 16
Cited by
Chemical and Pharmacological Aspects of Caffeic Acid and Its Activity in Hepatocarcinoma
Espíndola, K. M. M., Ferreira, R. G., Narvaez, L. E. M., Silva Rosario, A. C. R., da Silva, A. H. M., Silva, A. G. B., Vieira, A. P. O., & Monteiro, M. C. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00541 · Cited by 610
Abenavoli, L., Izzo, A. A., Milić, N., Cicala, C., Santini, A., & Capasso, R. (2018) · Phytotherapy Research · doi:10.1002/ptr.6171 · Cited by 463
Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma
Dimri, M., & Satyanarayana, A. (2020) · Cancers · doi:10.3390/cancers12020491 · Cited by 311
Mechanisms of hepatocellular carcinoma progression
Ogunwobi, O. O., Harricharran, T., Huaman, J., Galuza, A., Odumuwagun, O., Tan, Y., Ma, G. X., & Nguyen, M. T. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i19.2279 · Cited by 291
Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview
Rashed, W. M., Kandeil, M. A. M., Mahmoud, M. O., & Ezzat, S. (2020) · Journal of the Egyptian National Cancer Institute · doi:10.1186/s43046-020-0016-x · Cited by 283
Metadata
- Authors
- Dimitroulis, D., Damaskos, C., Valsami, S., Davakis, S., Garmpis, N., Spartalis, E., Athanasiou, A., Moris, D., Sakellariou, S., Kykalos, S., Tsourouflis, G., Garmpi, A., Delladetsima, I., Kontzoglou, K., & Kouraklis, G.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2017
- Volume
- 23
- Issue
- 29
- Pages
- 5282
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W2745218111
- Cited by
- 330
- References
- 68
- FWCI
- 16.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.